Table 2. Kinetics of immune responses elicited by YF-17D vaccination in human volunteers.
| Immune response type | Day | Month | Year | References | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4–6 | 7 | 8–13 | 14–16 | 17–30 | ||||||
| Innate immunity | NK | IFN-γ+ | ↑ | 41 | |||||||||
| IL-4+ | ↓ | ↓ | ↓ | 41 | |||||||||
| CD56+CD69+ | + | + | + | + | ↑↑↑ | + | + | 40 | |||||
| CD56+CD16+ | + | + | + | + | ↑↑↑ | + | + | 40 | |||||
| Monocyte | TNF-α+ | ↑ | ↑ | ↑ | 41,43,44 | ||||||||
| IL-10+ | ↑ | ↑ | 41,43 | ||||||||||
| pDC | ↑ | 34,38 | |||||||||||
| Adaptive immunity | CD8+ T | IFN-γ+ | + | + | ↑↑↑ | + | 18 | 26,45,49, 50 | |||||
| CD4+ T | IL-2+ | + | + | + | + | + | ↑↑↑ | + | 5 | 34,54,55 | |||
| TNF-α+ | + | + | + | + | ↑↑↑ | + | + | 34,54,55 | |||||
| IFN-γ+ | + | + | + | + | + | ↑↑↑ | + | 34,54,55 | |||||
| IL-4+ | + | + | + | + | + | ↑↑↑ | + | 34,54,55 | |||||
| nAbs | IgM | + | + | ↑↑↑ | + | 4 | 74,75 | ||||||
| IgG | + | + | + | + | Up to 35 | 59,64,69 | |||||||
| Viremia | + | + | ↑↑↑ | + | + | 25,49 | |||||||
+, Detected; ↑, up-regulated; ↓, down-regulated; ↑↑↑, peak titer.
nAbs, neutralizing antibodies